Combinations With Flt3 Inhibitors The Way Forward For Aml Treatment

Summary

The RATIFY trial (NCT00651261) showed that midostaurin, a Farhad Ravandi, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, shares some of the most important ... Mark Levis, MD, PhD, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, talks on the use of FMS- tyrosine kinase ... Harry Erba, MD, PhD, professor of medicine, director, Hematologic Malignancy Program, University of Alabama at Birmingham, ... In this video, Naval Daver, MD, of the University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of ... Alexander Perl, MD, University of Pennsylvania, Philadelphia, PA, discusses the role of Eunice Wang, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, discusses the mechanisms of resistance to This video is part of the HMP Education content archive and may include previously accredited educational material. While this ...